Author | Richard Smalley, MD

Articles

Role of Interferon-Alfa in NHL: Still Controversial?

August 01, 1999

Recombinant interferon-alfa (Intron A, Roferon-A) has been under investigation as a therapeutic agent for non-Hodgkin’s lymphoma (NHL) for 25 years. It has antitumor efficacy in a number of histologic subtypes but has not